FDA Provides Info On Boston Scientific’s Promus Element™ Plus Stent

Boston Scientific’s Promus Element™ Plus drug eluting stent was cleared by FDA last November with further indications being covered as recently as June 2012. Now the agency has issued an overview of the product, which can be found here.

Promus Element Plus is indicated for use in patients who have narrowing in coronary arteries with length less than or equal to 34 mm with reference vessel diameters greater than or equal to 2.25 mm and less than or equal to 4.00 mm.

Source: FDA